JP2017506214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506214A5 JP2017506214A5 JP2016544451A JP2016544451A JP2017506214A5 JP 2017506214 A5 JP2017506214 A5 JP 2017506214A5 JP 2016544451 A JP2016544451 A JP 2016544451A JP 2016544451 A JP2016544451 A JP 2016544451A JP 2017506214 A5 JP2017506214 A5 JP 2017506214A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding portion
- isolated antibody
- antibody
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461922893P | 2014-01-02 | 2014-01-02 | |
| US61/922,893 | 2014-01-02 | ||
| PCT/IL2015/050009 WO2015101998A1 (en) | 2014-01-02 | 2015-01-01 | Frizzled receptor antibodies for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017506214A JP2017506214A (ja) | 2017-03-02 |
| JP2017506214A5 true JP2017506214A5 (cg-RX-API-DMAC7.html) | 2018-01-25 |
Family
ID=53493369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544451A Pending JP2017506214A (ja) | 2014-01-02 | 2015-01-01 | 癌を治療するためのFrizzled受容体抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10465004B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3089995A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017506214A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2935630A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL246540A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015101998A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3089995A4 (en) | 2014-01-02 | 2017-11-29 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Frizzled receptor antibodies for treatment of cancer |
| WO2017100154A1 (en) * | 2015-12-07 | 2017-06-15 | Purdue Research Foundation | Inhibitors for proliferating cell nuclear antigen and uses |
| CN112159474B (zh) * | 2019-11-06 | 2021-11-19 | 上海健康医学院 | 一种靶向Frizzled7人源化抗体及其制备方法与应用 |
| WO2026051924A1 (zh) * | 2024-09-03 | 2026-03-12 | 浙江道尔生物科技有限公司 | 抗fzd7单域抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7867705B2 (en) * | 2004-09-21 | 2011-01-11 | Rhode Island Hospital, A Lifespan-Partner | Frizzled proteins and detection and treatment of cancer |
| EP2500360B1 (en) * | 2005-10-31 | 2015-08-05 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| EP2331136B1 (en) * | 2008-09-26 | 2018-01-10 | OncoMed Pharmaceuticals, Inc. | Frizzled-binding agents and uses thereof |
| WO2011004379A1 (en) * | 2009-07-10 | 2011-01-13 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Compositions and methods for treating cancer |
| EP3089995A4 (en) | 2014-01-02 | 2017-11-29 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Frizzled receptor antibodies for treatment of cancer |
-
2015
- 2015-01-01 EP EP15733130.7A patent/EP3089995A4/en not_active Withdrawn
- 2015-01-01 JP JP2016544451A patent/JP2017506214A/ja active Pending
- 2015-01-01 CA CA2935630A patent/CA2935630A1/en not_active Abandoned
- 2015-01-01 WO PCT/IL2015/050009 patent/WO2015101998A1/en not_active Ceased
- 2015-01-01 US US15/109,173 patent/US10465004B2/en not_active Expired - Fee Related
-
2016
- 2016-06-30 IL IL246540A patent/IL246540A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7345578B2 (ja) | 新規抗pd-l1抗体 | |
| US10604576B2 (en) | Antibodies and immunocytokines | |
| KR102022734B1 (ko) | 신규 조절제 및 용법 | |
| AU2011295715B9 (en) | Novel modulators and methods of use | |
| FI3332006T3 (fi) | Uusia anti-PD-L1-vasta-aineita | |
| RU2592672C2 (ru) | Новые модуляторы и способы их применения | |
| RU2012118643A (ru) | Антитела против сиглека-15 для лечения заболевания, связанного с потерей костной массы | |
| JP2015506912A5 (cg-RX-API-DMAC7.html) | ||
| JOP20190248A1 (ar) | بروتينات ربط مولد ضد trem2 واستخداماته | |
| JP2013513380A5 (cg-RX-API-DMAC7.html) | ||
| CN106536556A (zh) | 结合lgr5的人源化抗体 | |
| KR20140047127A (ko) | 암의 검출 및 진단을 위한 항체 i-3859의 용도 | |
| JP2020503359A5 (cg-RX-API-DMAC7.html) | ||
| CN113811545A (zh) | 对btn2具有特异性的抗体及其用途 | |
| JP7813235B2 (ja) | NPM1c陽性がんの免疫療法のための組成物および方法 | |
| WO2012019061A2 (en) | Novel effectors and methods of use | |
| WO2016090365A4 (en) | Pdk1 binding molecules and uses thereof | |
| JP6881658B2 (ja) | Pd−1/cd3二重特異性タンパク質による血液がん治療 | |
| US20230235074A1 (en) | Anti-bst2 antibodies targeting bst2 long isoform | |
| KR20190107967A (ko) | 한국인 위암 연관 유전자 단클론 항체 및 이의 제조방법 | |
| EA201992512A1 (ru) | Антигенсвязывающие белки, связывающие trem2, и пути их применения | |
| NZ739488A (en) | Novel anti-pd-1 antibodies |